BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7738942)

  • 1. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.
    Crilly A; McInness IB; McDonald AG; Watson J; Capell HA; Madhok R
    J Rheumatol; 1995 Feb; 22(2):224-6. PubMed ID: 7738942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of soluble interleukin-2-receptor and interleukin-6 with class-specific rheumatoid factors during low-dose methotrexate treatment in rheumatoid arthritis.
    Spadaro A; Taccari E; Riccieri V; Sensi F; Sili Scavalli A; Zoppini A
    Rev Rhum Engl Ed; 1997 Feb; 64(2):89-94. PubMed ID: 9085442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
    van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
    J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy.
    Franke S; Herrmann D; Hein G; Müller A; Stein G
    Eur J Med Res; 1997 Sep; 2(9):401-6. PubMed ID: 9300938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis.
    Chang DM; Weinblatt ME; Schur PH
    J Rheumatol; 1992 Nov; 19(11):1678-82. PubMed ID: 1491385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of nonsteroidal antiinflammatory drug therapy in early rheumatoid arthritis on serum levels of soluble interleukin 2 receptor, CD4, and CD8.
    Dooley MA; Cush JJ; Lipsky PE; Dawson DV; Pisetsky DS
    J Rheumatol; 1993 Nov; 20(11):1857-62. PubMed ID: 8308770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy.
    Kirkham BW; Davison SC; Corkill MM; Barbatis C; Panayi GS
    J Rheumatol; 1993 Jun; 20(6):935-9. PubMed ID: 8350327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
    Seitz M; Zwicker M; Wider B
    J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
    Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
    Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 receptor levels in sera of patients with rheumatoid arthritis treated with sulfasalazine, parenteral gold, or placebo.
    Merkel PA; Dooley MA; Dawson DV; Pisetsky DS; Polisson RP
    J Rheumatol; 1996 Nov; 23(11):1856-61. PubMed ID: 8923356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
    Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
    J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis.
    Wolf RE; Brelsford WG; Hall VC; Adams SB
    J Rheumatol; 1992 Apr; 19(4):524-8. PubMed ID: 1593571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent effect of cyclosporine on Th1/Th2 type cytokines in patients with severe, refractory rheumatoid arthritis.
    Kim WU; Cho ML; Kim SI; Yoo WH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Feb; 27(2):324-31. PubMed ID: 10685792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
    Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
    Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
    O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
    Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of FK506 and methotrexate on inflammatory cytokine levels in rat adjuvant-induced arthritis.
    Magari K; Miyata S; Nishigaki F; Ohkubo Y; Mutoh S; Goto T
    J Rheumatol; 2003 Oct; 30(10):2193-200. PubMed ID: 14528517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The serum level of soluble interleukin-2 receptors in patients with rheumatoid arthritis].
    Medvedev AN; Korshunov NI; Nasonov EL; Baranov AA; Shilkina NP
    Ter Arkh; 1996; 68(5):24-7. PubMed ID: 9082592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.